Cargando…
Metastasectomy in Leiomyosarcoma: A Systematic Review and Pooled Survival Analysis
SIMPLE SUMMARY: Leiomyosarcoma (LMS) is an aggressive soft tissue sarcoma with a poor prognosis. Approximately 40% of patients will develop metastatic disease. The optimal treatment for patients with metastatic LMS is not well established, and there are no randomized controlled trials regarding meta...
Autores principales: | Delisle, Megan, Alshamsan, Bader, Nagaratnam, Kalki, Smith, Denise, Wang, Ying, Srikanthan, Amirrtha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264936/ https://www.ncbi.nlm.nih.gov/pubmed/35804827 http://dx.doi.org/10.3390/cancers14133055 |
Ejemplares similares
-
Survival by histology among patients with bone and soft tissue sarcoma who undergo metastasectomy: protocol for a systematic review and meta-analysis
por: Wang, Ying, et al.
Publicado: (2020) -
Variations in Emergency Service Utilization among Cancer Survivors: Results from the Pan-Canadian Experiences of Cancer Patients in Transition Study Survey
por: Delisle, Megan, et al.
Publicado: (2023) -
Perceptions and attitudes of medical oncologists regarding fertility preservation and pregnancy in high‐risk cancer patients: A survey among Canadian medical oncologists
por: Alshamsan, Bader, et al.
Publicado: (2022) -
Temozolomide Chronotherapy in Glioma: A Systematic Review
por: Jia, Jason L., et al.
Publicado: (2023) -
Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy
por: Stork, Theresa, et al.
Publicado: (2022)